Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Shirabe

Showing results (361-370 of 834) with videos related to

Pageof 84
Sort By:
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|April 23, 2013
Fas-deficient fully allogeneic dendritic cells administered via an intratumoral injection route show efficient antitumor effects in murine modelsShinji Okano, Haruhiko Kondoh, Takeo Toshima, et al.
Case Reports in Gastroenterology|August 2, 2013
Feasible isolated liver transplantation for a cirrhotic patient on chronic hemodialysisKazutoyo Morita, Ken Shirabe, Tomoharu Yoshizumi, et al.
Pediatric Surgery International|April 21, 2015
Three-dimensional liver model based on preoperative CT images as a tool to assist in surgical planning for hepatoblastoma in a childRyota Souzaki, Yoshiaki Kinoshita, Satoshi Ieiri, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 3, 2015
Skeletal muscle mass assessed by computed tomography correlates to muscle strength and physical performance at a liver-related hospital experienceShinji Itoh, Ken Shirabe, Tomoharu Yoshizumi, et al.
Annals of Surgical Oncology|July 23, 2016
A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with CholangiocarcinomaAkira Watanabe, Kenichiro Araki, Keitarou Hirai, et al.
Journal of Hepatology|March 15, 2005
The newly established human hepatocyte cell line: application for the bioartificial liverNorifumi Harimoto, Akinobu Taketomi, Dai Kitagawa, et al.
Molecular Cancer Therapeutics|September 16, 2004
Muscle-targeted interleukin-12 gene therapy of orthotopic hepatocellular carcinoma in mice using in vivo electrosonoporationYo-Ichi Yamashita, Mitsuo Shimada, Ryosuke Minagawa, et al.
Oncology|August 28, 2010
The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinomaNorifumi Harimoto, Kenichi Taguchi, Ken Shirabe, et al.
Surgery Today|January 17, 2012
The long-term outcomes of patients with hepatocellular carcinoma after living donor liver transplantation: a comparison of right and left lobe graftsAkinobu Taketomi, Ken Shirabe, Takeo Toshima, et al.
Transplantation|October 6, 2011
Minimal hilar dissection prevents biliary anastomotic stricture after living donor liver transplantationToru Ikegami, Ken Shirabe, Kazutoyo Morita, et al.
Pageof 84

Showing results (361-370 of 834) with videos related to

Sort By:
Pageof 84
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|April 23, 2013
Fas-deficient fully allogeneic dendritic cells administered via an intratumoral injection route show efficient antitumor effects in murine modelsShinji Okano, Haruhiko Kondoh, Takeo Toshima, et al.
Case Reports in Gastroenterology|August 2, 2013
Feasible isolated liver transplantation for a cirrhotic patient on chronic hemodialysisKazutoyo Morita, Ken Shirabe, Tomoharu Yoshizumi, et al.
Pediatric Surgery International|April 21, 2015
Three-dimensional liver model based on preoperative CT images as a tool to assist in surgical planning for hepatoblastoma in a childRyota Souzaki, Yoshiaki Kinoshita, Satoshi Ieiri, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 3, 2015
Skeletal muscle mass assessed by computed tomography correlates to muscle strength and physical performance at a liver-related hospital experienceShinji Itoh, Ken Shirabe, Tomoharu Yoshizumi, et al.
Annals of Surgical Oncology|July 23, 2016
A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with CholangiocarcinomaAkira Watanabe, Kenichiro Araki, Keitarou Hirai, et al.
Journal of Hepatology|March 15, 2005
The newly established human hepatocyte cell line: application for the bioartificial liverNorifumi Harimoto, Akinobu Taketomi, Dai Kitagawa, et al.
Molecular Cancer Therapeutics|September 16, 2004
Muscle-targeted interleukin-12 gene therapy of orthotopic hepatocellular carcinoma in mice using in vivo electrosonoporationYo-Ichi Yamashita, Mitsuo Shimada, Ryosuke Minagawa, et al.
Oncology|August 28, 2010
The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinomaNorifumi Harimoto, Kenichi Taguchi, Ken Shirabe, et al.
Surgery Today|January 17, 2012
The long-term outcomes of patients with hepatocellular carcinoma after living donor liver transplantation: a comparison of right and left lobe graftsAkinobu Taketomi, Ken Shirabe, Takeo Toshima, et al.
Transplantation|October 6, 2011
Minimal hilar dissection prevents biliary anastomotic stricture after living donor liver transplantationToru Ikegami, Ken Shirabe, Kazutoyo Morita, et al.
Pageof 84